98%
921
2 minutes
20
Epistasis, or interactions in which alleles at one locus modify the fitness effects of alleles at other loci, plays a fundamental role in genetics, protein evolution, and many other areas of biology. Epistasis is typically quantified by computing the deviation from the expected fitness under an additive or multiplicative model using one of several formulae. However, these formulae are not all equivalent. Importantly, one widely used formula - which we call the formula - measures deviations from a fitness model on an scale, thus mixing two measurement scales. We show that for pairwise interactions, the chimeric formula yields a different magnitude, but the same sign (synergistic vs. antagonistic) of epistasis compared to the multiplicative formula that measures both fitness and deviations on a multiplicative scale. However, for higher-order interactions, we show that the chimeric formula can have both different magnitude sign compared to the multiplicative formula - thus confusing negative epistatic interactions with positive interactions, and vice versa. We resolve these inconsistencies by deriving fundamental connections between the different epistasis formulae and the parameters of the . Our results demonstrate that the additive and multiplicative epistasis formulae are more mathematically sound than the chimeric formula. Moreover, we demonstrate that the mathematical issues with the chimeric epistasis formula lead to markedly different biological interpretations of real data. Analyzing multi-gene knockout data in yeast, multi-way drug interactions in , and deep mutational scanning (DMS) of several proteins, we find that 10 - 60% of higher-order interactions have a change in sign with the multiplicative or additive epistasis formula. These sign changes result in qualitatively different findings on functional divergence in the yeast genome, synergistic vs. antagonistic drug interactions, and and epistasis between protein mutations. In particular, in the yeast data, the more appropriate multiplicative formula identifies nearly 500 additional negative three-way interactions, thus extending the trigenic interaction network by 25%.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11275791 | PMC |
http://dx.doi.org/10.1101/2024.07.17.603976 | DOI Listing |
Iran J Microbiol
August 2025
Department of Hepatitis and AIDS and Blood Borne Diseases, Pasteur Institute of Iran, Tehran, Iran.
Background And Objectives: Subunit vaccines have the privilege of utilizing immunogenic parts of the variable viruses. The current preventive vaccines against Hepatitis A are based on live-attenuated virus or wild-type growth in cell culture, which is a time-consuming and costly procedure. Thus, the investigation of immunogenic Hepatitis A Virus (HAV) regions seems to be a rational priority.
View Article and Find Full Text PDFTher Adv Med Oncol
July 2025
Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, No. 106 Zhongshan Second Road, Guangzhou 510080, China.
Immunotherapy now plays a key role in supplementing and even replacing conventional agents in tumor treatment. Immune checkpoint inhibitors (ICIs), represented by atezolizumab and durvalumab, have shown encouraging therapeutic effects in the combination chemotherapy for extensive-stage small cell lung cancer (SCLC) and have become preferred regimens. It has marked a seminal shift in the treatment landscape with achieving for the first time that overall survival exceed 1 year.
View Article and Find Full Text PDFFood Waterborne Parasitol
September 2025
Laboratory of Molecular Parasitology, Scientific Center of Zoology and Hydroecology, Yerevan, Armenia.
Toxoplasmosis, caused by the apicomplexan parasite , is a globally significant yet neglected disease that can cause serious clinical consequences in humans and extensive losses in the livestock industry. However, no effective vaccine has been provided for this parasite, so this study was designed to evaluate the immunogenicity of a chimeric multi-epitope antigen as a potential toxoplasmosis vaccine candidate in a murine model. The multi-epitope vaccine candidate, designed with bioinformatics tools, MGS: a chimera of MIC13, GRA1, and SAG1 antigens, was expressed in BL21 and purified by immobilized metal affinity chromatography using a His Ni-NTA column.
View Article and Find Full Text PDFRapid Commun Mass Spectrom
July 2025
Marine Chemistry, Faculty of Biology and Chemistry, University of Bremen, Bremen, Germany.
Rationale: The high chemodiversity of marine dissolved organic matter (DOM) has challenged identification of singular DOM components. To infer chemical structure features of DOM with accurately determined molecular formulas, we assessed if empirically determined elution properties of stoichiometrically identical isomers obtained from a chemical database would predict features, such as the type and number of functional groups, in structurally unknown DOM isomers.
Methods: DOM of different origin (North Sea, Southern Ocean) was analysed by LC-FT-MS using two different mass spectrometry methods.
Nat Commun
February 2025
Department of Computer Science, Princeton University, Princeton, NJ, USA.
Epistasis - the interaction between alleles at different genetic loci - plays a fundamental role in biology. However, several recent approaches quantify epistasis using a chimeric formula that measures deviations from a multiplicative fitness model on an additive scale, thus mixing two scales. Here, we show that for pairwise interactions, the chimeric formula yields a different magnitude but the same sign of epistasis compared to the multiplicative formula that measures both fitness and deviations on a multiplicative scale.
View Article and Find Full Text PDF